This report contains market size and forecasts of Megestrol Acetate (Megace) in global, including the following market information:
Global Megestrol Acetate (Megace) Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Megestrol Acetate (Megace) Market Sales, 2017-2022, 2023-2028, (M Unit)
Global top five Megestrol Acetate (Megace) companies in 2021 (%)
The global Megestrol Acetate (Megace) market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Suspension Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Megestrol Acetate (Megace) include Par Pharmaceutical (Endo International), Teva Pharmaceuticals, Hikma (West-ward Pharm, Roxane Labs..), TWi Pharmaceuticals, Hi-tech Pharmacal (Akorn), Nanjing Cuccess Pharmaceutical, Xianju pharma, Jiangsu Nhwa Pharmaceutical and Qingdao Guohai Biological Pharmaceutical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Megestrol Acetate (Megace) manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Megestrol Acetate (Megace) Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (M Unit)
Global Megestrol Acetate (Megace) Market Segment Percentages, by Type, 2021 (%)
Suspension
Tablets
Global Megestrol Acetate (Megace) Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (M Unit)
Global Megestrol Acetate (Megace) Market Segment Percentages, by Application, 2021 (%)
Hospital
Clinic
Other
Global Megestrol Acetate (Megace) Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (M Unit)
Global Megestrol Acetate (Megace) Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Megestrol Acetate (Megace) revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Megestrol Acetate (Megace) revenues share in global market, 2021 (%)
Key companies Megestrol Acetate (Megace) sales in global market, 2017-2022 (Estimated), (M Unit)
Key companies Megestrol Acetate (Megace) sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Par Pharmaceutical (Endo International)
Teva Pharmaceuticals
Hikma (West-ward Pharm, Roxane Labs..)
TWi Pharmaceuticals
Hi-tech Pharmacal (Akorn)
Nanjing Cuccess Pharmaceutical
Xianju pharma
Jiangsu Nhwa Pharmaceutical
Qingdao Guohai Biological Pharmaceutical
Grand Deten Pharmaceutical
Breckenridge Pharmaceutical
Apotex Corporation
Actiza Pharmaceutical
Morton Grove Pharmaceutical